Actin gamma 1 pseudogene 17 (ACTG1P17)

Actin gamma 1 pseudogene 17 (ACTG1P17), also known as LOC338963, is a **pseudogene** that shares homology with the protein-coding gene *ACTG1*, which encodes gamma-actin, a cytoplasmic structural protein. Pseudogenes are generally non-functional relics of genes resulting from duplication or retrotransposition events, and ACTG1P17 does not encode a functional protein. There is no evidence that ACTG1P17 produces a functional transcript or protein, nor is it implicated directly as a receptor, enzyme, transporter, or therapeutic target. However, as with some other pseudogenes, it could, in theory, participate in gene regulation through non-coding RNA mechanisms, potentially influencing the expression of its parental gene or related genes[2][4][6]. No specific biological functions, clinical roles, or drug interactions are attributed to ACTG1P17, and it is not currently considered significant for patient selection, disease prognosis, or therapeutic intervention. \n\n--- \n**Key points:**\n- This entry is a non-coding pseudogene, not a therapeutic target, receptor, enzyme, or other signaling/regulatory molecule.\n- There is nothing to suggest this is an actionable or clinically relevant molecular target in any current biomedical context.\n- Its main relevance may be for researchers studying pseudogene function or regulation of actin-related gene family members, but not for drug targeting or diagnostics[2][4][6].\n\nIf you intended to inquire about *ACTG1* rather than *ACTG1P17/LOC338963*, that gene encodes a crucial actin protein with broad roles in cell structure, motility, and disease, but ACTG1P17 is not the same entity[1][3][5].

Other names

ACTG1P17LOC338963epididymal protein pseudogene